Screener
Bicara Therapeutics BCAX Stock Issued During Period, Value, Stock Options Exercised
Stock Issued During Period, Value, Stock Options Exercised at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.
The source filing: Bicara Therapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033429
| Line item | Common Equity / Shares | Common Equity / Amount | Additional Paid in Capital | Accumulated / Other Comprehensive Income (Loss) | Accumulated Deficit | Total Stockholders' Equity |
|---|---|---|---|---|---|---|
| December 31, 2025 | 56,600,724 | $7 | $760,168 | $243 | $(358,966) | $401,452 |
| Issuance of common stock, and accompanying pre-funded warrants, net of issuance cost | 8,581,250 | 1 | 161,762 | — | — | 161,763 |
| Issuance of common stock upon exercise of stock options | 365,063 | — | 1,582 | — | — | 1,582 |
| Stock-based compensation | — | — | 5,858 | — | — | 5,858 |
| Unrealized loss on marketable securities, net of tax | — | — | — | (486) | — | (486) |
| Net loss | — | — | — | – | (56,211) | (56,211) |
| March 31, 2026 | 65,547,037 | $8 | $929,370 | $(243) | $(415,177) | $513,958 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bicara Therapeutics's stock issued during period, value, stock options exercised?
- Bicara Therapeutics (BCAX) reported stock issued during period, value, stock options exercised of $1.58M in Q1 2026.
- How has Bicara Therapeutics's stock issued during period, value, stock options exercised changed year-over-year?
- Bicara Therapeutics's stock issued during period, value, stock options exercised increased by 231.7% year-over-year, from $477K to $1.58M.
- What does stock issued during period, value, stock options exercised mean?
- The cash proceeds received by the company from the exercise of employee or director stock options. This metric indicates the extent to which equity-based compensation plans are being utilized and converted into actual share ownership. It serves as a proxy for the alignment between employee incentives and shareholder interests.
Ask your AI about Bicara Therapeutics's stock issued during period, value, stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude